<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Yoshizawa T</submitter><funding>Japan Agency for Medical Research and Development</funding><funding>Ministry of Education, Culture, Sports, Science and Technology</funding><pagination>5351-5360</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9709912</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>62(22)</volume><pubmed_abstract>Designing highly selective molecules for a drug target protein is a challenging task in drug discovery. This task can be regarded as a multiobjective problem that simultaneously satisfies criteria for various objectives, such as selectivity for a target protein, pharmacokinetic endpoints, and drug-like indices. Recent breakthroughs in artificial intelligence have accelerated the development of molecular structure generation methods, and various researchers have applied them to computational drug designs and successfully proposed promising drug candidates. However, designing efficient selective inhibitors with releasing activities against various homologs of a target protein remains a difficult issue. In this study, we developed a &lt;i>de novo&lt;/i> structure generator based on reinforcement le</pubmed_abstract><journal>Journal of chemical information and modeling</journal><pubmed_title>Selective Inhibitor Design for Kinase Homologs Using Multiobjective Monte Carlo Tree Search.</pubmed_title><pmcid>PMC9709912</pmcid><funding_grant_id>JP22ama121023</funding_grant_id><funding_grant_id>JP22nk0101111</funding_grant_id><pubmed_authors>Sato T</pubmed_authors><pubmed_authors>Honma T</pubmed_authors><pubmed_authors>Terayama K</pubmed_authors><pubmed_authors>Ishida S</pubmed_authors><pubmed_authors>Yoshizawa T</pubmed_authors><pubmed_authors>Ohta M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Selective Inhibitor Design for Kinase Homologs Using Multiobjective Monte Carlo Tree Search.</name><description>Designing highly selective molecules for a drug target protein is a challenging task in drug discovery. This task can be regarded as a multiobjective problem that simultaneously satisfies criteria for various objectives, such as selectivity for a target protein, pharmacokinetic endpoints, and drug-like indices. Recent breakthroughs in artificial intelligence have accelerated the development of molecular structure generation methods, and various researchers have applied them to computational drug designs and successfully proposed promising drug candidates. However, designing efficient selective inhibitors with releasing activities against various homologs of a target protein remains a difficult issue. In this study, we developed a &lt;i>de novo&lt;/i> structure generator based on reinforcement le</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-04T19:37:57.728Z</modification><creation>2025-04-04T19:37:57.728Z</creation></dates><accession>S-EPMC9709912</accession><cross_references><pubmed>36334094</pubmed><doi>10.1021/acs.jcim.2c00787</doi></cross_references></HashMap>